These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18318463)

  • 1. Design, synthesis, and SAR of new pyrrole-oxindole progesterone receptor modulators leading to 5-(7-fluoro-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile (WAY-255348).
    Fensome A; Adams WR; Adams AL; Berrodin TJ; Cohen J; Huselton C; Illenberger A; Kern JC; Hudak VA; Marella MA; Melenski EG; McComas CC; Mugford CA; Slayden OD; Yudt M; Zhang Z; Zhang P; Zhu Y; Winneker RC; Wrobel JE
    J Med Chem; 2008 Mar; 51(6):1861-73. PubMed ID: 18318463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-(3-Cyclopentyl-2-thioxo-2,3-dihydro-1H-benzimidazol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile: A novel, highly potent, selective, and orally active non-steroidal progesterone receptor agonist.
    Zhang P; Terefenko E; Kern J; Fensome A; Trybulski E; Unwalla R; Wrobel J; Lockhead S; Zhu Y; Cohen J; Lacava M; Winneker RC; Zhang Z
    Bioorg Med Chem; 2007 Oct; 15(20):6556-64. PubMed ID: 17681796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAR studies of 6-aryl-1,3-dihydrobenzimidazol-2-ones as progesterone receptor antagonists.
    Terefenko EA; Kern J; Fensome A; Wrobel J; Zhu Y; Cohen J; Winneker R; Zhang Z; Zhang P
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3600-3. PubMed ID: 15978807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-Methyl-1H-pyrrole-2-carbonitrile containing tetrahydronaphthalene derivatives as non-steroidal progesterone receptor antagonists.
    Kern JC; Terefenko E; Trybulski E; Berrodin TJ; Cohen J; Winneker RC; Yudt MR; Zhang Z; Zhu Y; Zhang P
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4816-8. PubMed ID: 20638844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel pyrrole-containing progesterone receptor modulators.
    Collins MA; Hudak V; Bender R; Fensome A; Zhang P; Miller L; Winneker RC; Zhang Z; Zhu Y; Cohen J; Unwalla RJ; Wrobel J
    Bioorg Med Chem Lett; 2004 May; 14(9):2185-9. PubMed ID: 15081005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of novel pyrrolo[2,3-a]carbazoles: 7-Chloro-2-oxo-3a-(2'-oxo-2',3'-dihydro-1'H-indol-3'-yl)-2,3,3a,4,5,10-hexahydro-pyrrolo[3,2-a]carbazole-1-carbonitrile as an efficient anticancer agent.
    Sathiyachandran P; Manogaran P; Nesterov VN; Padma VV; Rajendra Prasad KJ
    Eur J Med Chem; 2018 Apr; 150():851-863. PubMed ID: 29597168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget.
    Fensome A; Bender R; Chopra R; Cohen J; Collins MA; Hudak V; Malakian K; Lockhead S; Olland A; Svenson K; Terefenko EA; Unwalla RJ; Wilhelm JM; Wolfrom S; Zhu Y; Zhang Z; Zhang P; Winneker RC; Wrobel J
    J Med Chem; 2005 Aug; 48(16):5092-5. PubMed ID: 16078826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a novel mechanism of steroid receptor antagonism: WAY-255348 modulates progesterone receptor cellular localization and promoter interactions.
    Yudt MR; Russo LA; Berrodin TJ; Jelinsky SA; Ellis D; Cohen JC; Cooch N; Haglund E; Unwalla RJ; Fensome A; Wrobel J; Zhang Z; Nagpal S; Winneker RC
    Biochem Pharmacol; 2011 Dec; 82(11):1709-19. PubMed ID: 21854761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary asymmetric routes to (R)-2-(7-hydroxy-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetate.
    Schrader TO; Johnson BR; Lopez L; Kasem M; Gharbaoui T; Sengupta D; Buzard D; Basmadjian C; Jones RM
    Org Lett; 2012 Dec; 14(24):6306-9. PubMed ID: 23210718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of GABAA receptor subtypes to the anxiolytic-like, motor, and discriminative stimulus effects of benzodiazepines: studies with the functionally selective ligand SL651498 [6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyridol[3,4-b]indol-1-one].
    Licata SC; Platt DM; Cook JM; Sarma PV; Griebel G; Rowlett JK
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1118-25. PubMed ID: 15687371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 5-aryl-1,3-dihydro-indole-2-thiones. potent, orally active progesterone receptor agonists.
    Fensome A; Koko M; Wrobel J; Zhang P; Zhang Z; Cohen J; Lundeen S; Rudnick K; Zhu Y; Winneker R
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1317-20. PubMed ID: 12657272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Aryl indanones and derivatives as non-steroidal progesterone receptor modulators.
    Kern JC; Terefenko E; Trybulski E; Berrodin TJ; Cohen J; Winneker RC; Yudt MR; Zhang Z; Zhu Y; Zhang P
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6666-9. PubMed ID: 19864132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,5-Dihydro-benzo[e][1,4]oxazepin-2(1H)-ones containing a 7-(5'-cyanopyrrol-2-yl) group as nonsteroidal progesterone receptor modulators.
    Kern JC; Terefenko EA; Fensome A; Unwalla R; Wrobel J; Cohen J; Zhu Y; Berrodin TJ; Yudt MR; Winneker RC; Zhang Z; Zhang P
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5015-7. PubMed ID: 18722119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of 5-[5-fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase.
    Sun L; Liang C; Shirazian S; Zhou Y; Miller T; Cui J; Fukuda JY; Chu JY; Nematalla A; Wang X; Chen H; Sistla A; Luu TC; Tang F; Wei J; Tang C
    J Med Chem; 2003 Mar; 46(7):1116-9. PubMed ID: 12646019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of novel 3-aryl-4-(1H-indole-3yl)-1,5-dihydro-2H-pyrrole-2-ones as vascular endothelial growth factor receptor (VEGF-R) inhibitors.
    Peifer C; Selig R; Kinkel K; Ott D; Totzke F; Schächtele C; Heidenreich R; Röcken M; Schollmeyer D; Laufer S
    J Med Chem; 2008 Jul; 51(13):3814-24. PubMed ID: 18529047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of [18F]SU11248, a new potential PET tracer for imaging cancer tyrosine kinase.
    Wang JQ; Miller KD; Sledge GW; Zheng QH
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4380-4. PubMed ID: 16019210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New progesterone receptor antagonists: 3,3-disubstituted-5-aryloxindoles.
    Fensome A; Bender R; Cohen J; Collins MA; Mackner VA; Miller LL; Ullrich JW; Winneker R; Wrobel J; Zhang P; Zhang Z; Zhu Y
    Bioorg Med Chem Lett; 2002 Dec; 12(23):3487-90. PubMed ID: 12419390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new generation of progesterone receptor modulators.
    Winneker RC; Fensome A; Zhang P; Yudt MR; McComas CC; Unwalla RJ
    Steroids; 2008 Aug; 73(7):689-701. PubMed ID: 18472121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-alkylamides as a new class of synthetic histone deacetylase inhibitors. 1. Design, synthesis, biological evaluation, and binding mode studies performed through three different docking procedures.
    Mai A; Massa S; Ragno R; Cerbara I; Jesacher F; Loidl P; Brosch G
    J Med Chem; 2003 Feb; 46(4):512-24. PubMed ID: 12570373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig.
    Pullar IA; Boot JR; Broadmore RJ; Eyre TA; Cooper J; Sanger GJ; Wedley S; Mitchell SN
    Eur J Pharmacol; 2004 Jun; 493(1-3):85-93. PubMed ID: 15189767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.